Susannah Davies

510 total citations
8 papers, 292 citations indexed

About

Susannah Davies is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Susannah Davies has authored 8 papers receiving a total of 292 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 5 papers in Organic Chemistry and 1 paper in Oncology. Recurrent topics in Susannah Davies's work include Protein Kinase Regulation and GTPase Signaling (4 papers), Melanoma and MAPK Pathways (4 papers) and Phenothiazines and Benzothiazines Synthesis and Activities (2 papers). Susannah Davies is often cited by papers focused on Protein Kinase Regulation and GTPase Signaling (4 papers), Melanoma and MAPK Pathways (4 papers) and Phenothiazines and Benzothiazines Synthesis and Activities (2 papers). Susannah Davies collaborates with scholars based in United Kingdom and United States. Susannah Davies's co-authors include David M. Wilson, David K. Dean, Andrew K. Takle, Jon G.A. Steadman, Alessandra Gaiba, Frank D. King, A. Naylor, Alastair D. Reith, Murray J. B. Brown and Peter J. Lovell and has published in prestigious journals such as Journal of Medicinal Chemistry, Bioorganic & Medicinal Chemistry and Bioorganic & Medicinal Chemistry Letters.

In The Last Decade

Susannah Davies

8 papers receiving 278 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Susannah Davies United Kingdom 7 188 130 32 29 19 8 292
Jon G.A. Steadman United Kingdom 6 175 0.9× 103 0.8× 24 0.8× 29 1.0× 5 0.3× 7 278
Zhang‐Bao Xu United States 7 92 0.5× 184 1.4× 26 0.8× 57 2.0× 15 0.8× 8 287
Zeqi Huang United States 10 131 0.7× 113 0.9× 18 0.6× 46 1.6× 6 0.3× 15 236
Jeffrey Varnes United States 11 122 0.6× 97 0.7× 16 0.5× 46 1.6× 32 1.7× 20 260
Yoshiaki Washio United Kingdom 8 215 1.1× 192 1.5× 51 1.6× 50 1.7× 5 0.3× 11 373
Jamal El Bakali France 12 183 1.0× 157 1.2× 30 0.9× 25 0.9× 45 2.4× 24 405
Prashi Jain United States 13 129 0.7× 180 1.4× 26 0.8× 49 1.7× 25 1.3× 22 342
Bethany Hughes United States 9 64 0.3× 122 0.9× 32 1.0× 36 1.2× 9 0.5× 9 198
Tobias Gabriel Germany 7 146 0.8× 131 1.0× 30 0.9× 65 2.2× 8 0.4× 9 248
Whitney Silkworth United States 3 94 0.5× 89 0.7× 15 0.5× 17 0.6× 11 0.6× 5 227

Countries citing papers authored by Susannah Davies

Since Specialization
Citations

This map shows the geographic impact of Susannah Davies's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Susannah Davies with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Susannah Davies more than expected).

Fields of papers citing papers by Susannah Davies

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Susannah Davies. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Susannah Davies. The network helps show where Susannah Davies may publish in the future.

Co-authorship network of co-authors of Susannah Davies

This figure shows the co-authorship network connecting the top 25 collaborators of Susannah Davies. A scholar is included among the top collaborators of Susannah Davies based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Susannah Davies. Susannah Davies is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Takle, Andrew K., Mark J. Bamford, Susannah Davies, et al.. (2008). The identification of potent, selective and CNS penetrant furan-based inhibitors of B-Raf kinase. Bioorganic & Medicinal Chemistry Letters. 18(15). 4373–4376. 20 indexed citations
2.
Procopiou, Panayiotis A., Mark J. Bamford, Christopher R. Browning, et al.. (2007). 4-Acyl-1-(4-aminoalkoxyphenyl)-2-ketopiperazines as a Novel Class of Non-Brain-Penetrant Histamine H3 Receptor Antagonists. Journal of Medicinal Chemistry. 50(26). 6706–6717. 22 indexed citations
3.
Bamford, Mark J., Nicholas Bailey, Susannah Davies, et al.. (2005). (1H-Imidazo[4,5-c]pyridin-2-yl)-1,2,5-oxadiazol-3-ylamine derivatives: A novel class of potent MSK-1-inhibitors. Bioorganic & Medicinal Chemistry Letters. 15(14). 3402–3406. 30 indexed citations
4.
Takle, Andrew K., Murray J. B. Brown, Susannah Davies, et al.. (2005). The identification of potent and selective imidazole-based inhibitors of B-Raf kinase. Bioorganic & Medicinal Chemistry Letters. 16(2). 378–381. 170 indexed citations
5.
Bamford, Mark J., Nicholas Bailey, Susannah Davies, et al.. (2005). (1H-Imidazo[4,5-c]pyridin-2-yl)-1,2,5-oxadiazol-3-ylamine derivatives: Further optimisation as highly potent and selective MSK-1-inhibitors. Bioorganic & Medicinal Chemistry Letters. 15(14). 3407–3411. 19 indexed citations
6.
Bromidge, Steven M., Steven Dabbs, Susannah Davies, et al.. (2000). 1-[2-[(Heteroaryloxy)heteroaryl]carbamoyl]indolines: novel and selective 5-HT2C receptor inverse agonists with potential as antidepressant/Anxiolytic agents. Bioorganic & Medicinal Chemistry Letters. 10(16). 1863–1866. 16 indexed citations
7.
Bromidge, Steven M., Susannah Davies, D. Malcolm Duckworth, et al.. (2000). 1-[2-[(Heteroarylmethoxy)aryl]carbamoyl]indolines are selective and orally active 5-HT2C receptor inverse agonists. Bioorganic & Medicinal Chemistry Letters. 10(16). 1867–1870. 10 indexed citations
8.
Bromidge, Steven M., Steven Dabbs, David T. Davies, et al.. (1999). Model studies on a synthetically facile series of N-substituted phenyl-N′-pyridin-3-yl ureas leading to 1-(3-pyridylcarbamoyl) indolines that are potent and selective 5-HT2C/2B receptor antagonists. Bioorganic & Medicinal Chemistry. 7(12). 2767–2773. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jon G.A. Steadman Breakdown of academic impact, for papers by Zhang‐Bao Xu Breakdown of academic impact, for papers by Zeqi Huang Breakdown of academic impact, for papers by Jeffrey Varnes Breakdown of academic impact, for papers by Yoshiaki Washio Breakdown of academic impact, for papers by Jamal El Bakali Breakdown of academic impact, for papers by Prashi Jain Breakdown of academic impact, for papers by Bethany Hughes Breakdown of academic impact, for papers by Tobias Gabriel Breakdown of academic impact, for papers by Whitney Silkworth
Rankless by CCL
2026